BlackRock Investment Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

BlackRock Investment Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$5.23M	Buy	347,406 +56,601	+19%	+$748K	0.01%	1573
2016 Q3	$3.4M	Buy	290,805 +3,860	+1%	+$45.4K	﹤0.01%	1760
2016 Q2	$3.1M	Buy	286,945 +50,447	+21%	+$520K	﹤0.01%	1784
2016 Q1	$2.19M	Buy	236,498 +3,907	+2%	+$42K	﹤0.01%	1942
2015 Q4	$3.45M	Buy	232,591 +1,437	+0.6%	+$24K	﹤0.01%	1663
2015 Q3	$3.79M	Sell	231,154 -1,326	-0.6%	-$27.1K	0.01%	1576
2015 Q2	$5.3M	Buy	232,480 +65,824	+39%	+$1.31M	0.01%	1450
2015 Q1	$2.53M	Buy	166,656 +9,941	+6%	+$129K	﹤0.01%	1859
2014 Q4	$1.89M	Sell	156,715 -1,404	-0.9%	-$16K	﹤0.01%	2083
2014 Q3	$1.79M	Buy	158,119 +381	+0.2%	+$4.35K	﹤0.01%	2080
2014 Q2	$1.91M	Sell	157,738 -3,994	-2%	-$47.2K	﹤0.01%	2105
2014 Q1	$1.88M	Buy	161,732 +2,030	+1%	+$34.4K	﹤0.01%	2082
2013 Q4	$2.82M	Sell	159,702 -3,061	-2%	-$51.4K	﹤0.01%	1769
2013 Q3	$2.34M	Buy	162,763 +6,847	+4%	+$105K	﹤0.01%	1845
2013 Q2	$2.35M	Buy	+155,916	New	+$2.06M	﹤0.01%	1745

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock Investment Management's MNTA Position: Q4 2016 in Review

BlackRock Investment Management increased its Momenta Pharmaceuticals, Inc. (MNTA) stake by 19% in Q4 2016, buying an estimated $748K and bringing the position to 347,406 shares worth $5.23M. The position accounts for 0.01% of the portfolio, ranked #1573.

BlackRock Investment Management first reported a position in MNTA in Q2 2013 and has held it in 15 quarters since. The position peaked at $5.3M in Q2 2015. 160 funds tracked by Wall St. Rank hold MNTA as of Q4 2016.

BlackRock Investment Management held 347,406 shares of Momenta Pharmaceuticals, Inc. worth $5.23M as of Q4 2016.
BlackRock Investment Management bought 56,601 Momenta Pharmaceuticals, Inc. shares in Q4 2016, an estimated $748K.
Momenta Pharmaceuticals, Inc. made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1573 holding.
BlackRock Investment Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's Momenta Pharmaceuticals, Inc. position peaked at $5.3M in Q2 2015.
160 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.